Suchergebnisse - "Mamta K. Jain"

PubPharm (9)

1

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trialsResearch in context

in: EClinicalMedicine | 2024

von Ilias I. Siempos | Andre C. Kalil | Drifa Belhadi | +1270

2

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza

in: JCI Insight | 2023

von Hillary A. Vanderven | Deborah N. Wentworth | Win Min Han | +13

3

Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2023

von Sandra E. Safo | Lillian Haine | Jason Baker | +7

4

Persistent CMV pneumonitis in HIV infection: a case report

in: BMC Infectious Diseases | 2023

von Abbye W. Frederick | Ellen Kitchell | Clare McCormick-Baw | +2

5

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial

in: Frontiers in Pharmacology | 2022

von Mamta K. Jain | Mamta K. Jain | James A. De Lemos | +22

6

Host Cell Redox Alterations Promote Latent HIV-1 Reactivation through Atypical Transcription Factor Cooperativity

in: Viruses | 2022

von Emily Cruz-Lorenzo | Nora-Guadalupe P. Ramirez | Jeon Lee | +9

7

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.

in: PLoS ONE | 2020

von Gregory D Huhn | Moti Ramgopal | Mamta K Jain | +14

8

Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

in: BMC Medicine | 2017

von Christina Yek | Carolina de la Flor | John Marshall | +7

9

Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis.

in: PLoS ONE | 2013

von Huw Price | David Dunn | Deenan Pillay | +12

1
[1]